Abivax SA Sponsored ADR ABVX

91.06 (3.81) (4.02%) as of 25 Sep
Market cap
$8.2B
P/E
0.0×
Jun '26 Mar '26 Dec '25 Sep '25 Older periods
Current Ratio
5.97 8.25 8.75 7.86

+8 more quarters

Net Debt/EBITDA
4.89 8.92 7.47 6.88
Debt/Assets
0.26% 0.26% 0.32% 7.04%
Debt/Equity
0.00 0.00 0.00 0.09
Asset Turnover
0.00 0.00 0.00 0.00
Operating CF/Net income
0.44 1.04 0.23 0.48
Capex/Depreciation
(0.30) (0.15) (0.34) 0.02
Interest Coverage
0.00 0.00 0.00 0.00
Research and Development Expense of Revenue
0.00% 0.00% 0.00% 0.00%
Selling, General and Administrative Expense of Revenue
0.00% 0.00% 0.00% 0.00%
Intangible Assets out of Total Assets
0.05 0.05 0.04 0.04
Share Based Compensation of Revenue
0.00% 0.00% 0.00% 0.00%
Free Cash Flow per Share
(0.76) (0.75) (0.30) (1.17)
Cash per Share
6.00 7.40 8.76 9.60
Shareholders Equity per Share
5.35 6.37 7.41 8.19
Interest Debt per Share
0.00 0.00 0.00 0.00
Book value per Share
5.35 6.37 7.41 8.19
Free Cash Flow
(60.19) (59.19) (21.21) (85.56)
Working Capital
413.85 527.84 552.38 631.83
Capital Expenditures
(0.13) (0.06) (0.10) 0.01
Net Current Asset Value
385.65 463.09 477.57 559.30
Other line items
Quick Ratio
5.97 8.25 8.75 7.86
Revenue per Share
0.00 0.00 0.00 0.00
Operating CF per Share
(0.75) (0.75) (0.30) (1.17)
Capex per Share
0.00 0.00 0.00 0.00
Average Receivables
19.58 19.41 17.66 22.99
Average Payables
55.31 47.05 44.95 34.66
Average Assets
336.61 408.12 441.60 534.28
Average Common Equity
185.53 247.93 279.47 366.89
Capex to Sales
0.00 0.00 0.00 0.00
Net Profit Margin
0.00% 0.00% 0.00% 0.00%

Fold the line items

Columns are period end dates · fundamentals updated 23 Sep 2026